Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
SiriusPoint Ltd. SEC filings document the regulatory record of a global specialty insurance and reinsurance underwriter. Its 8-K filings report operating results, financial supplements, investor presentations, business-structure changes, executive transitions, and other material events. Regulation FD exhibits provide additional detail on underwriting performance, services income, investment results, capital management, and risk-based capital measures.
The company’s proxy materials describe board elections, director independence, committee assignments, executive compensation, shareholder voting matters, and governance practices. Filings also disclose SiriusPoint’s capital structure, including common stock and preference-share matters, and include records such as Form 25 for the removal from listing and registration of its 8.00% Resettable Fixed Rate Preference Shares, Series B.
SiriusPoint Ltd. announced that one of its subsidiaries entered into a definitive agreement to sell ArmadaCorp Capital, LLC, the holding company for its wholly owned supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc. for $250 million. The transaction’s closing is subject to customary closing conditions, including required regulatory approvals. The company also issued a press release describing the agreement, which is filed as an exhibit to this report.
Martin Hudson, a director of SiriusPoint Ltd. (SPNT), acquired 3,698 common shares on 09/09/2025 at a price of $18.59 per share. The purchase increases his beneficial ownership to 3,698 shares and includes restricted shares that vest in full on May 30, 2026, subject to his continued service as a director. The transaction was reported on a Form 4 and was signed by an attorney-in-fact on the reporting statement.
SiriusPoint Ltd. (SPNT) Form 3 reports that Martin Peter Hudson is identified as a director and the filing states that no securities are beneficially owned by the reporting person. The form notifies the issuer and investors that this individual has a director relationship but does not hold equity or derivative positions at the time of the statement.
SiriusPoint Ltd. reported that its board of directors appointed Martin Hudson as a Class III director, effective September 1, 2025. He will serve until the company’s 2028 annual general meeting of shareholders and until a successor is elected and qualified or an earlier departure.
Hudson, age 66, brings more than 40 years of international (re)insurance leadership experience, including roles as an independent non-executive director and chair across multiple insurance and reinsurance entities such as SiriusPoint International, Liberty Mutual entities, and Sirius International Managing Agency Ltd. The board concluded he should serve as a director based on his extensive industry and governance background.
The board determined that Hudson qualifies as an independent director under New York Stock Exchange and SEC rules. He will receive the same compensation as other non-employee directors and has entered into the company’s standard form of director indemnification agreement. The company stated there are no special arrangements, family relationships, or related-party transactions connected to his appointment. A press release announcing his appointment was issued on September 3, 2025 and filed as Exhibit 99.1.
Evan Cabat, identified as the Chief Accounting Officer of SiriusPoint Ltd. (SPNT), reported a change in his beneficial ownership of common shares following the vesting of restricted share units. The filing shows 588 shares were withheld to satisfy tax liabilities related to RSU vesting, recorded with transaction code F. After that withholding, Mr. Cabat beneficially owned 33,777 common shares, an amount the filer notes includes restricted shares. The disclosure was submitted via Form 4 and signed by an attorney-in-fact on behalf of Mr. Cabat.
Donald Smith & Co., Inc. and its DSCO Value Fund, L.P. report beneficial ownership of SiriusPoint Ltd common stock totaling 6,852,137 shares, representing 5.88% of the class. The filing shows Donald Smith & Co., Inc. holds the bulk of those shares with 6,593,154 shares of sole voting power and sole dispositive power, while DSCO Value Fund, L.P. holds 62,733 shares of sole voting and dispositive power. The reporting persons classify their holdings as held in the ordinary course of business and not for the purpose of influencing control.
This disclosure identifies the issuer as SiriusPoint Ltd and provides the issuer's principal executive office. The filing clarifies that no single advisory client of Donald Smith & Co., Inc. holds more than 5% of the class and states that various persons hold the remaining reported securities.
Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership of 5,700,000 shares of SiriusPoint Ltd., representing 4.9% of the approximately 116.6 million shares outstanding. The filing is made under Rule 13d-1(b), indicating a passive disclosure for holdings under 5%. The filing states the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The disclosure clarifies voting and dispositive power are held solely by the reporting person.
On 30 Jul 2025 SiriusPoint Ltd. (NYSE: SPNT) filed an 8-K announcing adoption of an Executive Severance Plan, effective 1 Aug 2025. The plan, approved by the board the same day, governs cash, benefit and equity payouts for two groups: (i) named executives/officers and (ii) other selected employees.
Executives terminated without cause or resigning for Good Reason receive, upon signing a release:
- One-time cash equal to 52 weeks base salary
- Prior-year STI target (if exit ≤ 31 Mar) or pro-rated current-year STI (≥ 1 Apr)
- Immediate vesting of any cash bonus
- Lump-sum of employer-paid medical, dental & vision premiums for 52 weeks
Change-in-Control (CiC): If separation occurs within 12 months of a CiC, cash base-pay and STI amounts are elevated to 150 % of the standard benefit. CiC is defined as: (1) >50 % voting power transfer, (2) sale of substantially all assets, or (3) replacement of a board majority within 24 months.
Other eligible employees receive 2 weeks base pay per year of service (min 6 mths, max 52 wks) plus parallel STI, bonus and benefit terms.
Equity: pro-rated vesting of RSUs/PSUs, extended option exercise (≤3 yrs) and full vesting of buy-out awards.
The plan standardises exit economics and could aid retention during strategic reviews, but it also increases potential cash outflows in layoffs or M&A events.
SiriusPoint (SPNT) Q2-25 10-Q highlights:
- Top line: Net premiums earned rose 10% YoY to $652 m, driven by 15% growth in Insurance & Services and 8% in Reinsurance.
- Underwriting: Combined ratio improved to 89.5% (-3.8 pts YoY) as the attritional loss ratio fell 2 pts and catastrophe losses were negligible (-0.1 pt).
- Income: Net income available to common shareholders dropped 46% YoY to $59.2 m; diluted EPS $0.50 (vs $0.57). The decline reflects lower net investment income (-13%) and a 77% drop in other revenues, partly offset by positive mark-to-market gains ($0.7 m vs -$54.9 m).
- Six-month view: Net premiums earned +8% to $1.28 bn; combined ratio 92.4% (flat). Net income to common $116.8 m (-42%); diluted EPS $0.98 (-7%).
- Balance sheet: Shareholders’ equity rose 9% YTD to $2.11 bn, aided by $51.8 m AFS unrealized gains and $125 m earnings, partially offset by $491 m share buybacks and $8 m preferred dividends.
- Capital actions: Repurchased $490.8 m of common shares YTD; common shares outstanding 116.8 m.
- Liquidity & cash: Operating cash burn narrowed to $26.8 m (vs $91.1 m). Cash & equivalents $923 m; debt $678 m (net increase $39 m).
Key ratios (Q2-25): Loss ratio 56.6%, acquisition cost ratio 26.1%, expense ratio 6.8%. Book value per share ≈ $18.0.
Management reports no material changes to accounting policies and continues to monitor segment profitability via underwriting income and service-fee results.
SiriusPoint (SPNT) Q2-25 10-Q highlights:
- Top line: Net premiums earned rose 10% YoY to $652 m, driven by 15% growth in Insurance & Services and 8% in Reinsurance.
- Underwriting: Combined ratio improved to 89.5% (-3.8 pts YoY) as the attritional loss ratio fell 2 pts and catastrophe losses were negligible (-0.1 pt).
- Income: Net income available to common shareholders dropped 46% YoY to $59.2 m; diluted EPS $0.50 (vs $0.57). The decline reflects lower net investment income (-13%) and a 77% drop in other revenues, partly offset by positive mark-to-market gains ($0.7 m vs -$54.9 m).
- Six-month view: Net premiums earned +8% to $1.28 bn; combined ratio 92.4% (flat). Net income to common $116.8 m (-42%); diluted EPS $0.98 (-7%).
- Balance sheet: Shareholders’ equity rose 9% YTD to $2.11 bn, aided by $51.8 m AFS unrealized gains and $125 m earnings, partially offset by $491 m share buybacks and $8 m preferred dividends.
- Capital actions: Repurchased $490.8 m of common shares YTD; common shares outstanding 116.8 m.
- Liquidity & cash: Operating cash burn narrowed to $26.8 m (vs $91.1 m). Cash & equivalents $923 m; debt $678 m (net increase $39 m).
Key ratios (Q2-25): Loss ratio 56.6%, acquisition cost ratio 26.1%, expense ratio 6.8%. Book value per share ≈ $18.0.
Management reports no material changes to accounting policies and continues to monitor segment profitability via underwriting income and service-fee results.